Presence of infection by Mycobacterium avium subsp. paratuberculosis in the blood of patients with Crohn’s Disease and control subjects shown by multiple laboratory culture and antibody methods

J. Todd Kuenstner*, Raghava Potula, Tim J. Bull, Irene R. Grant, Antonio Foddai, Saleh Naser, Horacio Bach, Peilin Zhang, Daohai Yu, Xiaoning Lu, Ira Shafran

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)
9 Downloads (Pure)


Mycobacterium avium subspecies paratuberculosis (MAP) has long been suspected to be involved in the etiology of Crohn’s disease (CD). An obligate intracellular pathogen, MAP persists and influences host macrophages. The primary goals of this study were to test new rapid culture methods for MAP in human subjects and to assess the degree of viable culturable MAP bacteremia in CD patients compared to controls. A secondary goal was to compare the efficacy of three culture methods plus a phage assay and four antibody assays performed in separate laboratories, to detect MAP from the parallel samples. Culture and serological MAP testing was performed blind on whole blood samples obtained from 201 subjects including 61 CD patients (two of the patients with CD had concurrent ulcerative colitis (UC)) and 140 non-CD controls (14 patients in this group had UC only). Viable MAP bacteremia was detected in a significant number of study subjects across all groups. This included Pozzato culture (124/201 or 62% of all subjects, 35/61 or 57% of CD patients), Phage assay (113/201 or 56% of all subjects, 28/61 or 46% of CD patients), TiKa culture (64/201 or 32% of all subjects, 22/61 or 36% of CD patients) and MGIT culture (36/201 or 18% of all subjects, 15/61 or 25% of CD patients). A link between MAP detection and CD was observed with MGIT culture and one of the antibody methods (Hsp65) confirming previous studies. Other detection methods showed no association between any of the groups tested. Nine subjects with a positive Phage assay (4/9) or MAP culture (5/9) were again positive with the Phage assay one year later. This study highlights viable MAP bacteremia is widespread in the study population including CD patients, those with other autoimmune conditions and asymptomatic healthy subjects.
Original languageEnglish
Pages (from-to)2054
Number of pages14
Issue number12
Early online date21 Dec 2020
Publication statusPublished - 22 Dec 2020


Dive into the research topics of 'Presence of infection by <i>Mycobacterium avium</i> subsp. <i>paratuberculosis</i> in the blood of patients with Crohn’s Disease and control subjects shown by multiple laboratory culture and antibody methods'. Together they form a unique fingerprint.

Cite this